Accelerate Diagnostics, Inc
DelistedCIK 727207fmd_15CJ0XPZJGGAJYBQ3GM98J1M9SManufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Aug 01, 2010 to Dec 31, 2024, 62 periods
Latest annual · FY2024
Millions- Total revenues
- 12
- Gross profit
- 3
- Operating income
- (35)
- Net income
- (50)
- Free cash flow
- (25)
Latest quarter · Q4 FY2024
Millions- Total revenues
- 3
- Gross profit
- 0
- Operating income
- (8)
- Net income
- (10)
- Free cash flow
- (5)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2024
- -0.2%
- Revenue, 5 yearsFY2019 to FY2024
- +4.7%
- Net income, 5 yearsFY2019 to FY2024
- n/m
Accelerate Diagnostics, Inc financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Revenue | $11.7 million | $12.1 million | -3% | 10-K 2025-03-21 · proof |
| Gross profit | $2.7 million | $2.6 million | +6% | 10-K 2025-03-21 · proof |
| Operating income | -$35.3 million | -$54 million | 10-K 2025-03-21 · proof | |
| Net income | -$50 million | -$61.6 million | 10-K 2025-03-21 · proof | |
| Cash from operating activities | -$24.2 million | -$40.2 million | 10-K 2025-03-21 · proof | |
| Free cash flow | -$24.7 million | -$41.2 million | 10-K 2025-03-21 · proof | |
| Total assets | $28.6 million | $31.4 million | -9% | 10-K 2025-03-21 · proof |
| Total liabilities | $84.6 million | $51.3 million | +65.1% | 10-K 2025-03-21 · proof |
| Cash and cash equivalents | $15.1 million | $12.1 million | +24.4% | 10-K 2025-03-21 · proof |
- What was Accelerate Diagnostics, Inc's revenue in fiscal 2024?
- Accelerate Diagnostics, Inc reported revenue of $11.7 million for fiscal 2024 (the year ended Dec 31, 2024), against $12.1 million the year before (-3%). Source: the 10-K filed with the SEC on Mar 21, 2025. SEC
- What was Accelerate Diagnostics, Inc's gross profit in fiscal 2024?
- Accelerate Diagnostics, Inc reported gross profit of $2.7 million for fiscal 2024 (the year ended Dec 31, 2024), against $2.6 million the year before (+6%). Source: the 10-K filed with the SEC on Mar 21, 2025. SEC
- What was Accelerate Diagnostics, Inc's operating income in fiscal 2024?
- Accelerate Diagnostics, Inc reported operating income of -$35.3 million for fiscal 2024 (the year ended Dec 31, 2024), against -$54 million the year before. Source: the 10-K filed with the SEC on Mar 21, 2025. SEC
- What was Accelerate Diagnostics, Inc's net income in fiscal 2024?
- Accelerate Diagnostics, Inc reported net income of -$50 million for fiscal 2024 (the year ended Dec 31, 2024), against -$61.6 million the year before. Source: the 10-K filed with the SEC on Mar 21, 2025. SEC
- What was Accelerate Diagnostics, Inc's cash from operating activities in fiscal 2024?
- Accelerate Diagnostics, Inc reported cash from operating activities of -$24.2 million for fiscal 2024 (the year ended Dec 31, 2024), against -$40.2 million the year before. Source: the 10-K filed with the SEC on Mar 21, 2025. SEC
- What was Accelerate Diagnostics, Inc's free cash flow in fiscal 2024?
- Accelerate Diagnostics, Inc reported free cash flow of -$24.7 million for fiscal 2024 (the year ended Dec 31, 2024), against -$41.2 million the year before. Source: the 10-K filed with the SEC on Mar 21, 2025. SEC
- What are Accelerate Diagnostics, Inc's total assets?
- As of Dec 31, 2024, Accelerate Diagnostics, Inc reported total assets of $28.6 million, against $31.4 million a year earlier (-9%). Source: the 10-K filed with the SEC on Mar 21, 2025. SEC
- What are Accelerate Diagnostics, Inc's total liabilities?
- As of Dec 31, 2024, Accelerate Diagnostics, Inc reported total liabilities of $84.6 million, against $51.3 million a year earlier (+65.1%). Source: the 10-K filed with the SEC on Mar 21, 2025. SEC
- What are Accelerate Diagnostics, Inc's cash and cash equivalents?
- As of Dec 31, 2024, Accelerate Diagnostics, Inc reported cash and cash equivalents of $15.1 million, against $12.1 million a year earlier (+24.4%). Source: the 10-K filed with the SEC on Mar 21, 2025. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:727207&period_type=annual&limit=5"Information only, not investment advice.